CLARITHROMYCIN 500 MG
CLARITHROMYCIN : 500 MG · DIN 02324490 · PRO DOC LIMITEE
Health Canada status: MARKETED
What is CLARITHROMYCIN?
CLARITHROMYCIN 500 MG contains CLARITHROMYCIN : 500 MG. It is listed in the Health Canada Drug Product Database under DIN 02324490, held by PRO DOC LIMITEE, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 23-Dec-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02324490 |
|---|---|
| Brand name | CLARITHROMYCIN |
| Generic / active ingredient | CLARITHROMYCIN : 500 MG |
| Manufacturer | PRO DOC LIMITEE |
| Strength | 500 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J01FA09 CLARITHROMYCIN |
| AHFS class | 08:12.12.08 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 23-Dec-2025 |
| Original market date | 2009-10-08 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code J01FA09 CLARITHROMYCIN. 21 of 45 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-CLARITHROMYCIN | 250 MG | TABLET | APOTEX INC | MARKETED | DIN 02274744 |
| APO-CLARITHROMYCIN | 500 MG | TABLET | APOTEX INC | MARKETED | DIN 02274752 |
| APO-CLARITHROMYCIN XL | 500 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED | DIN 02413345 |
| BIAXIN | 125 MG / 5 ML | GRANULES FOR SUSPENSION | BGP PHARMA ULC | MARKETED | DIN 02146908 |
| BIAXIN | 250 MG / 5 ML | GRANULES FOR SUSPENSION | BGP PHARMA ULC | MARKETED | DIN 02244641 |
| BIAXIN BID | 250 MG | TABLET | BGP PHARMA ULC | MARKETED | DIN 01984853 |
| BIAXIN BID | 500 MG | TABLET | BGP PHARMA ULC | MARKETED | DIN 02126710 |
| CLARITHROMYCIN | 250 MG | TABLET | PRO DOC LIMITEE | MARKETED | DIN 02324482 |
| CLARITHROMYCIN | 250 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02442469 |
| CLARITHROMYCIN | 250 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02466120 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.